R&D
The SK bioscience R&D Center is building a vaccine development platform
based on advanced technology and research capabilities
to create vaccines that will improve the health of people around the world.
based on advanced technology and research capabilities
to create vaccines that will improve the health of people around the world.
Introduction of sophisticated research technology suitable for various vaccine types
Mouse over to see the status of vaccine development based on our research.
Platform Technologies
Cell line
Engineering
Engineering
- Suspension MDCK cell
- Suspension Vero cell
Mammalian
Cell Culture
Cell Culture
- Suspension
- Adherent
- Microcarrier
Glyco
-conjugation
-conjugation
- Fermentation
- Conjugation
Genetic
Engineering
Engineering
- Baculovirus Expression
- Genetic Recombination (including viral vector)
- Reverse Genetics
- cFlu
- PCV
- Zoster
- Varicella
- Rota
- HPV
- TCV
- NRRV
- MCV/MenB
- Rota, Influenza, RSV
- RSV, MERS, ZIKA, COVID19
- Influenza, Rota, Polio, Rabies, JEV, Dengue, EV81, Yellow Fever, Hep A
- iNTS
- Pan-Sarbecovirus
- Nasal Spray (Miniprotein)
| Basic Research / Preclinical |
Phase Ⅰ/Ⅱ | Phase Ⅲ | BLA | Commercial |
|---|---|---|---|---|
Next generation (with Sanofi Pasteur) |
||||